Thapakorn Jaroentomeechai

Title: Thapakorn Jaroentomeechai: Innovator in Cell-Free Glycoprotein Synthesis

Introduction

Thapakorn Jaroentomeechai is a prominent inventor based in Ithaca, NY (US). He has made significant contributions to the field of biotechnology, particularly in the area of cell-free glycoprotein synthesis. With a total of 8 patents to his name, Jaroentomeechai's work has the potential to revolutionize vaccine development and protein synthesis.

Latest Patents

Among his latest patents is the invention related to cell-free glycoprotein synthesis (CFGPS) in prokaryotic cell lysates enriched with components for glycosylation. This patent discloses components and systems that utilize engineered prokaryotic cell strains, enabling the cell-free synthesis of glycoproteins. Another notable patent involves the synthesis of bioconjugate vaccines in prokaryotic cell lysates. This invention outlines methods and systems for synthesizing glycosylated proteins that can be utilized in vaccines, including anti-bacterial vaccines. The glycosylated proteins may include a bacterial polysaccharide conjugated to a carrier, which is essential for generating an immune response in immunized hosts.

Career Highlights

Thapakorn Jaroentomeechai has worked at prestigious institutions such as Northwestern University and Cornell University. His research has focused on innovative methods for protein synthesis, contributing to advancements in biotechnology and vaccine development.

Collaborations

Throughout his career, Jaroentomeechai has collaborated with notable colleagues, including Michael Christopher Jewett and Jessica Carol Stark. These collaborations have further enhanced his research and contributions to the field.

Conclusion

Thapakorn Jaroentomeechai is a leading inventor whose work in cell-free glycoprotein synthesis is paving the way for new advancements in biotechnology and vaccine development. His innovative patents and collaborations highlight his significant impact on the field.